NYSE · MISCELLANEOUS CHEMICAL PRODUCTS · LARGE CAP
Cabot Corporation CBT
18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY4 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$3.7B
▼ 7.0% vs FY2024
Dividend streak
4 yrs
Raised every year since 2022
EPS · FY25
$6.02
Dividend / sh · FY25
$1.76
Payout · FY25
29%
ROE · FY25
22.3%
Net margin · FY25
8.9%
Dividend coverage
3.4×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 3.7B
Revenue, FY2025 · full 18-year series below
Revenue
Net income
9 cents of every revenue dollar became profit this year.
Per share
USD 6.02
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 3.4 times — the rest stayed in the company.
Profitability
22.3%
Return on equity, FY2025
ROE
Operating margin16.7%
Net margin8.9%
Return on assets8.8%
Each USD of equity produced 22 cents of profit this year.
Returned to shareholders
USD 256.0M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 96.0M
Net buybacksUSD 160.0M
Share of profit77.3%
Consecutive raises4 years
USD 96.0M in dividends and USD 160.0M in buybacks — 77% of the year's profit went back to shareholders.
Growth
+7.3% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−4.9%
+7.3%
+2.6%
+2.1%
Net income
+16.6%
+5.2%
EPS, diluted
+18.5%
Dividend / share
+5.9%
+4.7%
+7.2%
Returned to shareholders
+25.0%
+16.2%
+5.3%
+12.0%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.05B
Shares outstanding, FY2025
Change, 5 years−6.4%
Change, 10 years−15.4%
The share count shrank 6% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 3.8B
total assets, end of FY2025
Total assetsUSD 3.8B
EquityUSD 1.6B
CashUSD 258.0M
Gross debtUSD 1.1B
Net debtUSD 858.0M
Current ratio1.61×
Net debt stands at 55% of equity.
History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
3.7
4.0
3.9
4.3
3.4
2.6
3.3
3.2
2.7
2.4
2.9
3.6
3.5
3.3
3.1
2.7
2.1
3.2
Operating income $B
0.6
0.6
0.5
0.4
0.5
0.0
0.3
0.1
0.3
0.2
−0.3
0.3
0.3
0.3
0.2
0.2
−0.1
0.2
EBITDA $B
0.8
0.8
0.7
0.5
0.6
0.2
0.5
0.3
0.5
0.4
−0.1
0.5
0.5
0.4
0.4
0.3
0.1
0.3
Income tax $B
0.2
0.1
−0.0
0.1
0.1
0.2
0.1
0.2
0.0
0.0
−0.0
0.1
0.1
0.1
0.0
0.0
−0.0
0.0
Net income $B
0.3
0.4
0.4
0.2
0.2
−0.2
0.2
−0.1
0.2
0.1
−0.3
0.2
0.2
0.4
0.2
0.2
−0.1
0.1
EPS, diluted $
6.02
6.72
7.73
3.62
4.34
−4.21
2.63
−1.85
3.91
2.32
−5.27
3.03
2.36
5.99
3.57
2.35
−1.25
1.32
Dividend / sh $
1.76
1.66
1.54
1.48
1.40
1.40
1.36
1.29
1.23
1.04
0.88
0.84
0.80
0.76
0.72
0.72
0.72
·
Payout %
29
24
20
40
32
−34
51
−71
31
44
−17
27
33
13
20
31
−62
55
ROE %
22.3
28.3
41.2
22.7
30.5
−28.2
14.6
−8.5
17.9
11.7
−21.0
10.2
8.1
23.5
16.9
12.6
−6.8
·
Shares out B
0.05
0.05
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
63860.78
0.07
0.07
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
69 of 70
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 1 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed